Skip to main content

Cheek

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
Sculptra Aethestic reconsituted with 8ml Sterile Water for InjectionN/A1 trial
Active Trials
NCT04595331Completed111Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaSculptra Aethestic reconsituted with 8ml Sterile Water for Injection

Clinical Trials (1)

Total enrollment: 111 patients across 1 trials

NCT04595331GaldermaSculptra Aethestic reconsituted with 8ml Sterile Water for Injection

Open Label Extension for 43USSA1812

Start: Nov 2019Est. completion: Jul 2022111 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.